IQVIA runs clinical trials and sells health data for drug companies.
IQVIA Holdings Inc. (IQV) is expected to report earnings on Tuesday, October 27, 2026, before the open. Estimated release time 07:04 ET. Consensus EPS estimate is $3.25.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-28 | Jun 2026 qtr | $3.03 | $3.15 | +4.0% | $4.37B |
| 2026-05-05 | Mar 2026 qtr | $2.82 | $2.90 | +2.8% | $4.15B |
| 2026-02-05 | Dec 2025 qtr | $3.40 | $3.42 | +0.6% | $4.36B |
| 2025-10-28 | Sep 2025 qtr | $2.98 | $3.00 | +0.7% | $4.10B |
| 2025-07-22 | Jun 2025 qtr | $2.77 | $2.81 | +1.4% | $4.02B |
| 2025-05-06 | Mar 2025 qtr | $2.63 | $2.70 | +2.7% | $3.83B |
| 2025-02-06 | Dec 2024 qtr | $3.11 | $3.12 | +0.3% | $3.96B |
| 2024-10-31 | Sep 2024 qtr | $2.82 | $2.84 | +0.7% | $3.90B |
IQV has beaten consensus EPS in 8 of its last 8 scored quarters.
See IQV on the live calendar →